Does Tirzepatide Cause Cancer | What the Evidence Shows in 2025–2026
Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, has become one of the most powerful medications available for improving blood sugar and achieving significant, sustained weight loss. Weekly injections often lead to reductions of 15–22 % of starting body weight over 12–18 months in clinical studies, results that frequently … Read more